Achieve Life Sciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Achieve Life Sciences announces its 2026 Annual Meeting of Stockholders, detailing proposals including director elections, auditor ratification, executive compensation approval, and a significant increase in authorized shares.
NASDAQ
Achieve Life Sciences is holding its annual stockholder meeting on June 4, 2025, to elect directors, ratify the appointment of its accounting firm, and approve an amendment to its equity incentive plan.
NASDAQ
DEF 14A: Achieve Life Sciences Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Achieve Life Sciences will hold its annual stockholders meeting virtually on June 5, 2024, to elect directors and ratify the appointment of its independent accounting firm.